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Mosquitoes transmit some of the most deadly infectious
diseases of humans. Although malaria is the best known,
mosquitoes also transmit a wide variety of viruses and other
pathogens. Arthropod-transmitted viruses (arboviruses)
include the causative agents of dengue, yellow fever, West
Nile virus, chikungunya, and many others. The life cycle of
these viruses typically depends on transmission from a
suitable vertebrate host via a mosquito vector to another
suitable vertebrate, and so on for ever. For some of these
viruses, such as dengue, humans are the only suitable
vertebrate species across most or all of their range; others,
such as West Nile virus, can infect a wide range of
vertebrates. The mosquito is exposed to the pathogen when
she (only female mosquitoes bite) takes a blood meal from
an infectious vertebrate. The virus infects the mosquito,
typically first in the midgut and then disseminating through
the body. When the salivary glands become infected, so that
virus is present in the mosquito’s saliva, she becomes
infectious. The next time she takes a blood meal, her food
source is exposed to the virus. If this individual becomes
infected, for a period of time it will become infectious to
other mosquitoes that bite it, and so the virus continues to
propagate and spread.
Although insects lack the adaptive immune system of
mammals, they are by no means merely passive hosts and
vectors for these viruses; rather, they have multiple innate
immune defenses against the various microbial challenges
they encounter. RNA interference (RNAi) is one of the
mosquito’s major defenses against arboviruses, and
suppression of this pathway has previously been shown to
increase viral load in infected mosquitoes [1,2]. Two recent
papers shed more light on the role of this system in insect
antiviral innate immunity. Writing in BMC Microbiology,
Cirimotich et al. [3] show that Sindbis virus engineered to
express a suppressor of RNAi produces much more virus
than normal in infected mosquitoes, and that this
engineered virus is lethal to a range of mosquito species.
Previous studies used transient knockdown of components
of the RNAi pathway; Cirimotich et al. use a protein that
binds to double-stranded RNA (dsRNA) and presumably
protects it from processing in the RNAi pathway. Although
either approach might have pleiotropic effects, both
indicate a key role for the RNAi pathway in reducing virus
replication and titer. In this regard, in a recent paper in
Nature, Saleh et al. [4] show that Drosophila can mount a
systemic RNAi-based response to viruses so that uninfected
cells at distal locations can prepare a defense against
infection. This response was shown to depend on a dsRNA
uptake pathway; mutant flies defective in this pathway are
hypersensitive to infection with Drosophila C virus and
Sindbis virus.
A Ab bs st tr ra ac ct t
A recent paper in BMC Microbiology shows how suppression of mosquito innate immunity
against a virus that the mosquito can normally tolerate increases mosquito mortality. This is
just one of several approaches that may soon bring genetics-based mosquito control methods
from the laboratory into the field.
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As well as their interest in terms of basic immunology, the
mosquito’s antiviral defenses are significant from an applied
perspective. If they could be artificially boosted to the point
that infected mosquitoes do not themselves become
infectious, mosquitoes that cannot transmit a specific virus,
or perhaps even a range of viruses, could be produced.
Antiviral RNAi has already been used to confer resistance to
dengue virus in transgenic mosquitoes, by expressing a
hairpin RNA corresponding to part of the virus [5]. This
long hairpin has the significant advantage of being relatively
resistant to mutation of the virus target, as it presumably
targets multiple viral sequences. Constitutive expression of a
large hairpin RNA may be deleterious, but this potential
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Self-complementary RNA with sequences from dengue virus is expressed from a promoter that expresses in the gut of the mosquito soon after a
blood meal [5]. This RNA folds into a hairpin conformation with an extended double-stranded region. This double-stranded RNA is cut into 20-25bp
fragments by Dicer. These fragments are bound by the RISC complex of proteins and one strand is removed. The RISC complex is now primed to
bind and cleave target sequences from an infecting dengue virus, preventing translation from the RNA and replication of the virus.
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virusproblem was minimized by using a promoter that expresses
only in the midgut - the first cells to be infected - and only
following a blood meal.
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A virus-resistant strain of mosquitoes in the laboratory is,
however, only a curiosity or a research tool. To have an
impact on disease transmission, the virus-resistance gene(s)
must spread within the vector population in the wild. For
diseases such as dengue, where remarkably few competent
vectors are required to sustain epidemic transmission [6],
such a resistance gene would have to spread to a high allele
frequency, so that practically all mosquitoes in the target
population carried at least one copy. Unfortunately,
insertion and expression of a transgene imposes a fitness
penalty; this may be small, but will still tend to make the
transgene decrease in frequency over time, even if a large
number are initially introduced [7].
If infection were itself highly deleterious, resistance might
be a positive fitness trait, perhaps enough to cause the
resistance gene to spread to fixation. But the viruses carried
seem to have remarkably little negative impact on the
mosquito vector. An infected mosquito does not clear the
virus and remains infectious for the rest of her life. So
simply shortening the life expectancy of female mosquitoes
is potentially an effective way to reduce transmission. A first
step towards a genetic control strategy using this principle
was recently achieved, using a pathogenic mutant version of
the intracellular bacterium Wolbachia pipiens, which reduces
the lifespan of mosquitoes that carry it [8].
If the resistance transgene will not spread through a
population on its own, then further genetic tricks are
needed to make it spread. Natural self-spreading genetic
systems include obligate bacterial endosymbionts such as
Wolbachia and selfish DNA elements such as active trans-
posons. However, artificial versions of self-spreading
systems have proved remarkably difficult to construct,
although a demonstration of spreading in Drosophila of an
artificial DNA element based on the Tribolium castaneum
selfish DNA system MEDEA (maternal-effect dominant
embryonic arrest) [9] is a very promising development.
Several questions remain regarding these self-spreading
systems. ‘Can we get them to spread?’ is important, but so is
‘Can we get them to stop?’ Both Wolbachia and Medea are
extremely difficult to remove from a target population after
release - probably impossible in the case of Wolbachia - and
also difficult or impossible to stop from spreading beyond
the target population, perhaps even to all populations of
the species worldwide. This is new territory for genetic
engineering and such use or outcomes may well be
controversial. However, it is not an entirely new concept -
analogies can be drawn with the introduction of exotic
biocontrol agents, for which some of the same issues arise.
P Po op pu ul la at ti io on n   s su up pp pr re es ss si io on n   u us si in ng g   g ge en ne et ti ic ca al ll ly y   e en ng gi in ne ee er re ed d
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The strategy outlined above is commonly known as
‘population replacement’: a wild vector population is
converted to a modified one in which the mosquitoes have
reduced vectorial capacity. The other main strategy for
genetic control of mosquitoes is ‘population suppression’.
Here the objective is not to change the properties of the
vector mosquitoes but to reduce their number, as in the case
of the increased mortality induced by Cirimotich et al. [3].
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( (a a) ) In population replacement strategies, the wild population is invaded
by a heritable modification (e.g. transgene [5,9] or pathogenic
Wolbachia [8]) that reduces the vector competence of the mosquitoes
that carry it. The number of competent vectors therefore declines, but
the total number of (female) mosquitoes remains relatively constant,
though possibly with some transient change during the invasion. ( (b b) ) In
contrast, a population suppression strategy aims to reduce the total
number of vector mosquitoes. The two panels illustrate the changes in
female population number and type over time for the two strategies. In
both cases the situation will eventually reverse due to various pressures
such as resistance, mutation, immigration, etc, unless some maintenance
activities are undertaken.
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Wild typeThis is a more familiar objective, in that it is also the aim of
most source-reduction and chemical insecticide programs.
The major current strategy in this area is based on the use of
genetically sterile mosquitoes. In principle, large numbers
of sterile male mosquitoes are released so that a wild female
has a good chance of mating with a sterile male and so
produces no or fewer progeny than usual. The population
therefore tends to decline, and if enough sterile males can
be released for long enough, the population collapses. This
sterile insect technique (SIT) has been used for decades to
control some major agricultural pests [10], sterilizing the
insects by irradiating them before release. Applying
conventional SIT to mosquitoes has proved problematic,
but genetic modifications should be able to overcome many
of the key difficulties and limitations. The leading
genetically modified sterile release system, known as RIDL®
(release of insects carrying a dominant lethal [11]), is ready
to enter field trials for Aedes aegypti.
Genetics-based control systems share some attractive
characteristics. They tend to be extremely species-specific, as
the modified insects will mate only with their own species.
The self-spreading systems are hard to develop but may be
relatively cheap to deploy, as the genetic system does much
of the work. Sterile-release methods such as RIDL® are
relatively cheap to develop, but need regular releases of
sterile insects to maintain sufficient sterile males in the
field. This self-limiting nature - stop releasing and the
transgene will rapidly disappear from the field population -
may, however, be better accepted by the public and
regulators, and these systems are likely to be the first ones
used in the field.
None of these systems should be seen as a ‘magic bullet’.
Self-spreading systems will undoubtedly fail over time, due
to mutation and pathogen evolution, and replacement
versions will be required. Sterile-release methods will be
much more effective in the context of an integrated vector
management program than on their own. All of these
methods will have to be tested in the context of different
health systems, cultures and ecosystems; experience will
determine where each is more or less valuable. Nonetheless,
these powerful genetics-based vector-control tools, about to
emerge from the laboratory into the field, provide rare new
hope for the control, and perhaps one day elimination, of
some of the world’s major infectious diseases.
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